2020
DOI: 10.1155/2020/1517596
|View full text |Cite
|
Sign up to set email alerts
|

Jingui Shenqi Pills Regulate Bone‐Fat Balance in Murine Ovariectomy‐Induced Osteoporosis with Kidney Yang Deficiency

Abstract: Jingui Shenqi Pills (JGSQP) have been a staple of traditional Chinese medicine for thousands of years, used primarily as a treatment for kidney yang deficiency (KYD). In vitro analyses of JGSQP revealed strong induction of osteogenic differentiation and inhibition of adipogenic differentiation in bone-marrow-derived mesenchymal stem/stromal cells. However, the mechanisms by which JGSQP regulate the bone-fat balance in murine ovariectomy-induced osteoporosis with KYD have not been reported. Materials and Method… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 50 publications
0
7
0
Order By: Relevance
“…With the prolongation of life span, the incidence rate of PMOP and fragility fracture is increasing year by year. According to the recent report showed that fragility fractures are related to up 50% of the disability rate and 20% of the mortality rate [ 9 ]. The medical expenses related to fragility fractures in China are expected to reach 163 billion RMB in 2050.…”
Section: Discussionmentioning
confidence: 99%
“…With the prolongation of life span, the incidence rate of PMOP and fragility fracture is increasing year by year. According to the recent report showed that fragility fractures are related to up 50% of the disability rate and 20% of the mortality rate [ 9 ]. The medical expenses related to fragility fractures in China are expected to reach 163 billion RMB in 2050.…”
Section: Discussionmentioning
confidence: 99%
“…With the prolongation of life span, the incidence rate of PMOP and fragility fracture is increasing year by year. According to Shang Q et al [9] showed that fragility fractures are related to up 50% of the disability rate and 20% of the mortality rate. The medical expenses related to fragility fractures in China are expected to reach 163 billion RMB in 2050.…”
Section: Dicussionmentioning
confidence: 99%
“…The Guifu Dihuang pill (GFDHP, Chinese name 桂附地黄丸), composed of eight herbs, is a classical Chinese medicine for the treatment of kidney yang deficiency (KYD) syndrome [ 5 ]. It is also called the Jinkui Shenqi pill because it was first recorded in the Synopsis of Golden Chamber written by Zhang Zhongjing approximately 2000 years ago [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…It had been used as an immunomodulator for preventing renal and immune hypofunction, particularly chronic nephritis, diabetes, hypothyroidism, adrenocortical hypofunction, sexual hypofunction, chronic bronchitis, asthma, and COPD [ 7 ]. According to the theory of Traditional Chinese Medicine (TCM), the long-term KYD can induce gradually deteriorating “lung inflation” and “phlegm retention,” which in turn accelerate the development of the KYD disease and eventually lead to the emergence of a malignant phenotype [ 5 ]. Thus, the eight herbs in GFDHP, most of which treat lung-distension and phlegm retention, would be helpful in recovering pulmonary ventilation function in patients with COPD [ 8 ].…”
Section: Introductionmentioning
confidence: 99%